Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Determinants of the creatinine clearance to glomerular filtration rate ratio in patients with chronic kidney disease: a cross-sectional study

Authors: Yen-chung Lin, Nisha Bansal, Eric Vittinghoff, Alan S Go, Chi-yuan Hsu

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Creatinine secretion, as quantified by the ratio of creatinine clearance (CrCl) to glomerular filtration rate (GFR), may introduce another source of error when using serum creatinine concentration to estimate GFR. Few studies have examined determinants of the CrCl/GFR ratio. We sought to study whether higher levels of albuminuria would be associated with higher, and being non-Hispanic black with lower, CrCl/GFR ratio.

Methods

We did a cross-sectional analysis of 1342 patients with chronic kidney disease from the Chronic Renal Insufficiency Cohort (CRIC) who had baseline measure of iothalamate GFR (iGFR) and 24-hour urine collections. Our predictors included urine albumin as determined from 24-hour urine collections (categorized as: <30, 30-299, 300-2999 and ≥3000 mg), and race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic). Our outcome was CrCl/iGFR ratio, a measure of creatinine secretion.

Results

Mean iGFR was 48.0 ± 19.9 mL/min/1.73 m2, median albuminuria was 84 mg per day, and 36.8% of the study participants were non-Hispanic black. Mean CrCl/iGFR ratio was 1.19 ± 0.48. There was no association between the CrCl/iGFR ratio and urine albumin (coefficient 0.11 [95% CI−0.01-0.22] for higest verus lowest levels of albuminuria, p = 0.07). Also, there was no association between race/ethnicity and CrCl/iGFR ratio (coefficient for non-Hispanic blacks was−0.03 [95% CI−0.09-0.03] compared with whites, p = 0.38).

Conclusions

Contrary to what had been suggested by prior smaller studies, CrCl/GFR ratio does not vary with degree of proteinuria or race/ethnicity. The ratio is also closer to 1.0 than reported by several frequently cited reports in the literature.
Appendix
Available only for authorised users
Literature
2.
go back to reference Berlyne GM, Varley H, Nilwarangkur S, Hoerni M: Endogenous-creatinine clearance and glomerular-filtration rate. Lancet. 1964, 2 (7365): 874-876.CrossRefPubMed Berlyne GM, Varley H, Nilwarangkur S, Hoerni M: Endogenous-creatinine clearance and glomerular-filtration rate. Lancet. 1964, 2 (7365): 874-876.CrossRefPubMed
3.
go back to reference Bauer JH, Brooks CS, Burch RN: Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis. 1982, 2 (3): 337-346.CrossRefPubMed Bauer JH, Brooks CS, Burch RN: Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis. 1982, 2 (3): 337-346.CrossRefPubMed
4.
go back to reference Branten AJ, Vervoort G, Wetzels JF: Serum creatinine is a poor marker of GFR in nephrotic syndrome. Nephrol Dial Transplant. 2005, 20 (4): 707-711. 10.1093/ndt/gfh719.CrossRefPubMed Branten AJ, Vervoort G, Wetzels JF: Serum creatinine is a poor marker of GFR in nephrotic syndrome. Nephrol Dial Transplant. 2005, 20 (4): 707-711. 10.1093/ndt/gfh719.CrossRefPubMed
5.
go back to reference Coresh J, Toto RD, Kirk KA, Whelton PK, Massry S, Jones C, Agodoa L, Van Lente F: Creatinine clearance as a measure of GFR in screenees for the African-American study of kidney disease and hypertension pilot study. Am J Kidney Dis. 1998, 32 (1): 32-42. 10.1053/ajkd.1998.v32.pm9669421.CrossRefPubMed Coresh J, Toto RD, Kirk KA, Whelton PK, Massry S, Jones C, Agodoa L, Van Lente F: Creatinine clearance as a measure of GFR in screenees for the African-American study of kidney disease and hypertension pilot study. Am J Kidney Dis. 1998, 32 (1): 32-42. 10.1053/ajkd.1998.v32.pm9669421.CrossRefPubMed
6.
go back to reference Hsu CY, Chertow GM, Curhan GC: Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int. 2002, 61 (5): 1567-1576. 10.1046/j.1523-1755.2002.00299.x.CrossRefPubMed Hsu CY, Chertow GM, Curhan GC: Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int. 2002, 61 (5): 1567-1576. 10.1046/j.1523-1755.2002.00299.x.CrossRefPubMed
7.
go back to reference Shemesh O, Golbetz H, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985, 28 (5): 830-838. 10.1038/ki.1985.205.CrossRefPubMed Shemesh O, Golbetz H, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985, 28 (5): 830-838. 10.1038/ki.1985.205.CrossRefPubMed
8.
go back to reference Martin H: Laboratory measurement of urine albumin and urine total protein in screening for proteinuria in chronic kidney disease. Clin Biochem Rev. 2011, 32 (2): 97-102.PubMedPubMedCentral Martin H: Laboratory measurement of urine albumin and urine total protein in screening for proteinuria in chronic kidney disease. Clin Biochem Rev. 2011, 32 (2): 97-102.PubMedPubMedCentral
9.
go back to reference Wheeler DC, Becker GJ: Summary of KDIGO guideline: what do we really know about management of blood pressure in patients with chronic kidney disease?. Kidney Int. 2013, 83 (3): 377-383. 10.1038/ki.2012.425.CrossRefPubMed Wheeler DC, Becker GJ: Summary of KDIGO guideline: what do we really know about management of blood pressure in patients with chronic kidney disease?. Kidney Int. 2013, 83 (3): 377-383. 10.1038/ki.2012.425.CrossRefPubMed
10.
go back to reference Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, et al: Chronic renal insufficiency cohort (CRIC) study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009, 4 (8): 1302-1311. 10.2215/CJN.00070109.CrossRefPubMedPubMedCentral Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, et al: Chronic renal insufficiency cohort (CRIC) study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009, 4 (8): 1302-1311. 10.2215/CJN.00070109.CrossRefPubMedPubMedCentral
11.
go back to reference Hsu CY, Propert K, Xie D, Hamm L, He J, Miller E, Ojo A, Shlipak M, Teal V, Townsend R, et al: Measured GFR does not outperform estimated GFR in predicting CKD-related complications. J Am Soc Nephrol. 2011, 22 (10): 1931-1937. 10.1681/ASN.2010101077.CrossRefPubMedPubMedCentral Hsu CY, Propert K, Xie D, Hamm L, He J, Miller E, Ojo A, Shlipak M, Teal V, Townsend R, et al: Measured GFR does not outperform estimated GFR in predicting CKD-related complications. J Am Soc Nephrol. 2011, 22 (10): 1931-1937. 10.1681/ASN.2010101077.CrossRefPubMedPubMedCentral
12.
go back to reference Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, Fink JC, Franklin-Becker ED, Go AS, Hamm LL, et al: The chronic renal insufficiency cohort (CRIC) study: design and methods. J Am Soc Nephrol. 2003, 14 (7 Suppl 2): S148-S153.CrossRefPubMed Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, Fink JC, Franklin-Becker ED, Go AS, Hamm LL, et al: The chronic renal insufficiency cohort (CRIC) study: design and methods. J Am Soc Nephrol. 2003, 14 (7 Suppl 2): S148-S153.CrossRefPubMed
13.
go back to reference Levey AS, Berg RL, Gassman JJ, Hall PM, Walker WG: Creatinine filtration, secretion and excretion during progressive renal disease: modification of diet in renal disease (MDRD) study group. Kidney Int Suppl. 1989, 27: S73-S80.PubMed Levey AS, Berg RL, Gassman JJ, Hall PM, Walker WG: Creatinine filtration, secretion and excretion during progressive renal disease: modification of diet in renal disease (MDRD) study group. Kidney Int Suppl. 1989, 27: S73-S80.PubMed
14.
go back to reference Anderson AH, Yang W, Hsu CY, Joffe MM, Leonard MB, Xie D, Chen J, Greene T, Jaar BG, Kao P, et al: Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2012, 60 (2): 250-261. 10.1053/j.ajkd.2012.04.012.CrossRefPubMedPubMedCentral Anderson AH, Yang W, Hsu CY, Joffe MM, Leonard MB, Xie D, Chen J, Greene T, Jaar BG, Kao P, et al: Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2012, 60 (2): 250-261. 10.1053/j.ajkd.2012.04.012.CrossRefPubMedPubMedCentral
15.
go back to reference Joffe M, Hsu CY, Feldman HI, Weir M, Landis JR, Hamm LL: Variability of creatinine measurements in clinical laboratories: results from the CRIC study. Am J Nephrol. 2010, 31 (5): 426-434. 10.1159/000296250.CrossRefPubMedPubMedCentral Joffe M, Hsu CY, Feldman HI, Weir M, Landis JR, Hamm LL: Variability of creatinine measurements in clinical laboratories: results from the CRIC study. Am J Nephrol. 2010, 31 (5): 426-434. 10.1159/000296250.CrossRefPubMedPubMedCentral
16.
go back to reference Levey AS, Greene T, Kusek JW, Beck GJ: A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000, 11: 155A-abst Levey AS, Greene T, Kusek JW, Beck GJ: A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000, 11: 155A-abst
17.
go back to reference Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F: Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007, 53 (4): 766-772. 10.1373/clinchem.2006.077180.CrossRefPubMed Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F: Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007, 53 (4): 766-772. 10.1373/clinchem.2006.077180.CrossRefPubMed
18.
go back to reference Reznichenko A, Sinkeler SJ, Snieder H, van den Born J, De Borst MH, Damman J, Van Dijk MC, Van Goor H, Hepkema BG, Hillebrands JL, et al: SLC22A2 is associated with tubular creatinine secretion and bias of estimated GFR in renal transplantation. Physiol Genomics. 2013, 45 (6): 201-209. 10.1152/physiolgenomics.00087.2012.CrossRefPubMed Reznichenko A, Sinkeler SJ, Snieder H, van den Born J, De Borst MH, Damman J, Van Dijk MC, Van Goor H, Hepkema BG, Hillebrands JL, et al: SLC22A2 is associated with tubular creatinine secretion and bias of estimated GFR in renal transplantation. Physiol Genomics. 2013, 45 (6): 201-209. 10.1152/physiolgenomics.00087.2012.CrossRefPubMed
19.
go back to reference Levey AS, Perrone RD, Madias NE: Serum creatinine and renal function. Annu Rev Med. 1988, 39: 465-490. 10.1146/annurev.me.39.020188.002341.CrossRefPubMed Levey AS, Perrone RD, Madias NE: Serum creatinine and renal function. Annu Rev Med. 1988, 39: 465-490. 10.1146/annurev.me.39.020188.002341.CrossRefPubMed
20.
go back to reference K/DOQI: Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39 (2 Suppl 1): S1-S266. K/DOQI: Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39 (2 Suppl 1): S1-S266.
21.
go back to reference Perrone RD, Steinman TI, Beck GJ, Skibinski CI, Royal HD, Lawlor M, Hunsicker LG: Utility of radioisotopic filtration markers in chronic renal-insufficiency–simultaneous comparison of I-125 iothalamate, Yb-169 Dtpa, Tc-99 m-Dtpa, and inulin. Am J Kidney Dis. 1990, 16 (3): 224-235.CrossRefPubMed Perrone RD, Steinman TI, Beck GJ, Skibinski CI, Royal HD, Lawlor M, Hunsicker LG: Utility of radioisotopic filtration markers in chronic renal-insufficiency–simultaneous comparison of I-125 iothalamate, Yb-169 Dtpa, Tc-99 m-Dtpa, and inulin. Am J Kidney Dis. 1990, 16 (3): 224-235.CrossRefPubMed
22.
go back to reference Carrie BJ, Golbetz HV, Michaels AS, Myers BD: Creatinine: an inadequate filtration marker in glomerular diseases. Am J Med. 1980, 69 (2): 177-182. 10.1016/0002-9343(80)90376-9.CrossRefPubMed Carrie BJ, Golbetz HV, Michaels AS, Myers BD: Creatinine: an inadequate filtration marker in glomerular diseases. Am J Med. 1980, 69 (2): 177-182. 10.1016/0002-9343(80)90376-9.CrossRefPubMed
23.
go back to reference Anderson CF, Jaecks DM, Ballon HS, De Palma JR, Cutler RE: Renal handling of creatinine in nephrotic and non-nephrotic patients. Clin Sci. 1970, 38 (5): 555-562.CrossRefPubMed Anderson CF, Jaecks DM, Ballon HS, De Palma JR, Cutler RE: Renal handling of creatinine in nephrotic and non-nephrotic patients. Clin Sci. 1970, 38 (5): 555-562.CrossRefPubMed
24.
go back to reference Hilton PJ, Roth Z, Lavender S, Jones NF: Creatinine clearance in patients with proteinuria. Lancet. 1969, 2 (7632): 1215-1216.CrossRefPubMed Hilton PJ, Roth Z, Lavender S, Jones NF: Creatinine clearance in patients with proteinuria. Lancet. 1969, 2 (7632): 1215-1216.CrossRefPubMed
25.
go back to reference Kemperman FAW, Silberbusch J, Slaats EH, Prins AM, Weber JA, Krediet RT, Arisz L: Estimation of the glomerular filtration rate in NIDDM patients from plasma creatinine concentration after cimetidine administration. Diabetes Care. 1998, 21 (2): 216-220. 10.2337/diacare.21.2.216.CrossRefPubMed Kemperman FAW, Silberbusch J, Slaats EH, Prins AM, Weber JA, Krediet RT, Arisz L: Estimation of the glomerular filtration rate in NIDDM patients from plasma creatinine concentration after cimetidine administration. Diabetes Care. 1998, 21 (2): 216-220. 10.2337/diacare.21.2.216.CrossRefPubMed
26.
go back to reference Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J, Salive M, Jones CP, Agodoa LY: Serum creatinine levels in the US population: third national health and nutrition examination survey. Am J Kidney Dis. 1998, 32 (6): 992-999. 10.1016/S0272-6386(98)70074-5.CrossRefPubMed Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J, Salive M, Jones CP, Agodoa LY: Serum creatinine levels in the US population: third national health and nutrition examination survey. Am J Kidney Dis. 1998, 32 (6): 992-999. 10.1016/S0272-6386(98)70074-5.CrossRefPubMed
27.
go back to reference Levey AS, Bosch JP, Coggins CH, et al: Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the modification of diet in renal disease study. J Am Soc Nephrol. 1996, 7 (4): 556-566. Levey AS, Bosch JP, Coggins CH, et al: Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the modification of diet in renal disease study. J Am Soc Nephrol. 1996, 7 (4): 556-566.
28.
go back to reference Caregaro L, Menon F, Angeli P, Amodio P, Merkel C, Bortoluzzi A, Alberino F, Gatta A: Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med. 1994, 154 (2): 201-205. 10.1001/archinte.1994.00420020117013.CrossRefPubMed Caregaro L, Menon F, Angeli P, Amodio P, Merkel C, Bortoluzzi A, Alberino F, Gatta A: Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med. 1994, 154 (2): 201-205. 10.1001/archinte.1994.00420020117013.CrossRefPubMed
29.
go back to reference Gottlieb SS, Skettino SL, Wolff A, Beckman E, Fisher ML, Freudenberger R, Gladwell T, Marshall J, Cines M, Bennett D, et al: Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol. 2000, 35 (1): 56-59. 10.1016/S0735-1097(99)00532-X.CrossRefPubMed Gottlieb SS, Skettino SL, Wolff A, Beckman E, Fisher ML, Freudenberger R, Gladwell T, Marshall J, Cines M, Bennett D, et al: Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol. 2000, 35 (1): 56-59. 10.1016/S0735-1097(99)00532-X.CrossRefPubMed
30.
go back to reference Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, et al: BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002, 105 (11): 1348-1353. 10.1161/hc1102.105264.CrossRefPubMed Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, et al: BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002, 105 (11): 1348-1353. 10.1161/hc1102.105264.CrossRefPubMed
31.
go back to reference Tobias GJ, Mc LR, Hopper J: Endogenous creatinine clearance: a valuable clinical test of glomerular filtration and a prognostic guide in chronic renal disease. N Engl J Med. 1962, 266: 317-323. 10.1056/NEJM196202152660701.CrossRefPubMed Tobias GJ, Mc LR, Hopper J: Endogenous creatinine clearance: a valuable clinical test of glomerular filtration and a prognostic guide in chronic renal disease. N Engl J Med. 1962, 266: 317-323. 10.1056/NEJM196202152660701.CrossRefPubMed
32.
go back to reference Kim KE, Onesti G, Ramirez O, Brest AN, Swartz C: Creatinine clearance in renal disease: a reappraisal. Br Med J. 1969, 4 (5674): 11-14. 10.1136/bmj.4.5674.11.CrossRefPubMedPubMedCentral Kim KE, Onesti G, Ramirez O, Brest AN, Swartz C: Creatinine clearance in renal disease: a reappraisal. Br Med J. 1969, 4 (5674): 11-14. 10.1136/bmj.4.5674.11.CrossRefPubMedPubMedCentral
33.
go back to reference Bauer JH, Brooks CS, Burch RN: Renal function studies in man with advanced renal insufficiency. Am J Kidney Dis. 1982, 2 (1): 30-35.CrossRefPubMed Bauer JH, Brooks CS, Burch RN: Renal function studies in man with advanced renal insufficiency. Am J Kidney Dis. 1982, 2 (1): 30-35.CrossRefPubMed
Metadata
Title
Determinants of the creatinine clearance to glomerular filtration rate ratio in patients with chronic kidney disease: a cross-sectional study
Authors
Yen-chung Lin
Nisha Bansal
Eric Vittinghoff
Alan S Go
Chi-yuan Hsu
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-268

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.